122 related articles for article (PubMed ID: 18991098)
41.
Boyanova O; Dolashka P; Toncheva D; Rammensee HG; Stevanović S
Biomed Rep; 2013 Mar; 1(2):235-238. PubMed ID: 24648926
[TBL] [Abstract][Full Text] [Related]
42. The role of metabolism in the immunogenicity of drugs: production of antibodies to a horseradish peroxidase generated conjugate paracetamol.
Chesham J; Davies GE
Clin Exp Immunol; 1985 Aug; 61(2):224-31. PubMed ID: 2412741
[TBL] [Abstract][Full Text] [Related]
43. Novel mechanisms of specific suppression of anti-hapten antibody response mediated by monoclonal anti-carrier antibody.
Sumida T; Taniguchi M
J Immunol; 1985 Jun; 134(6):3675-81. PubMed ID: 3157746
[TBL] [Abstract][Full Text] [Related]
44. Purified protein derivative (PPD) as an immunogen carrier elicits high antigen specificity to haptens.
De Silva BS; Egodage KL; Wilson GS
Bioconjug Chem; 1999; 10(3):496-501. PubMed ID: 10346883
[TBL] [Abstract][Full Text] [Related]
45. Antitumor activity and carrier properties of novel hemocyanins coupled to a mimotope of GD2 ganglioside.
Palacios M; Tampe R; Del Campo M; Zhong TY; López MN; Salazar-Onfray F; Becker MI
Eur J Med Chem; 2018 Apr; 150():74-86. PubMed ID: 29524730
[TBL] [Abstract][Full Text] [Related]
46. Selective Cytotoxicity and Changes in Protein Expression of T24 Bladder Carcinoma Permanent Cell Line after Treatment with Hemocyanins.
Dolashki A; Antonova O; Velkova L; Kaynarov D; Voelter W; Dolashka P
Curr Med Chem; 2022; 29(42):6479-6498. PubMed ID: 35993464
[TBL] [Abstract][Full Text] [Related]
47. Keyhole limpet hemocyanin type 2 (KLH2): detection and immunolocalization of a labile functional unit h.
Gebauer W; Harris JR; Geisthardt G; Markl J
J Struct Biol; 1999 Dec; 128(3):280-6. PubMed ID: 10633067
[TBL] [Abstract][Full Text] [Related]
48. Rapana thomasiana hemocyanin (RtH): comparison of the two isoforms, RtH1 and RtH2, at 19A and 16A resolution.
Cheng K; Koeck PJ; Elmlund H; Idakieva K; Parvanova K; Schwarz H; Ternström T; Hebert H
Micron; 2006; 37(6):566-76. PubMed ID: 16466927
[TBL] [Abstract][Full Text] [Related]
49. Antigen-specific and nonspecific mediators of T cell/B cell cooperation. I. Evidence for their production by different T cells.
Marrack PC; Kappler JW
J Immunol; 1975 Mar; 114(3):1116-25. PubMed ID: 1089726
[TBL] [Abstract][Full Text] [Related]
50. Assessment of humoral immune response in mink (Mustela vison): antibody production and detection.
Smits JE; Godson DL
J Wildl Dis; 1996 Apr; 32(2):358-61. PubMed ID: 8722279
[TBL] [Abstract][Full Text] [Related]
51. Characterization of the carbohydrate moieties of the functional unit RvH1-a of Rapana venosa haemocyanin using HPLC/electrospray ionization MS and glycosidase digestion.
Dolashka-Angelova P; Beck A; Dolashki A; Beltramini M; Stevanovic S; Salvato B; Voelter W
Biochem J; 2003 Aug; 374(Pt 1):185-92. PubMed ID: 12732096
[TBL] [Abstract][Full Text] [Related]
52. Amino acid sequence and glycosylation of functional unit RtH2-e from Rapana thomasiana (gastropod) hemocyanin.
Stoeva S; Idakieva K; Betzel C; Genov N; Voelter W
Arch Biochem Biophys; 2002 Mar; 399(2):149-58. PubMed ID: 11888200
[TBL] [Abstract][Full Text] [Related]
53. Anti-cancer properties of gastropodan hemocyanins in murine model of colon carcinoma.
Gesheva V; Chausheva S; Mihaylova N; Manoylov I; Doumanova L; Idakieva K; Tchorbanov A
BMC Immunol; 2014 Aug; 15():34. PubMed ID: 25168124
[TBL] [Abstract][Full Text] [Related]
54. Modulation of the immune response using Rapana thomasiana hemocyanin.
Tchorbanov A; Idakieva K; Mihaylova N; Doumanova L
Int Immunopharmacol; 2008 Jul; 8(7):1033-8. PubMed ID: 18486915
[TBL] [Abstract][Full Text] [Related]
55. Structural analysis and molecular modeling of the RvH2-e functional unit of Rapana venosa hemocyanin.
Velkova L; Dolashka P; Dolashki A; Voelter W; Atanasov B
Biochim Biophys Acta; 2010 Dec; 1804(12):2177-82. PubMed ID: 20807592
[TBL] [Abstract][Full Text] [Related]
56. Keyhole limpet hemocyanin (KLH): a biomedical review.
Harris JR; Markl J
Micron; 1999 Dec; 30(6):597-623. PubMed ID: 10544506
[TBL] [Abstract][Full Text] [Related]
57. [Immunogenic activity of hemocyanin from the hemolymph of Helix pomatia and Octopus vulgaris].
Pitzurra L; Cenci E; Sbaraglia G; Sebastiani L
Boll Soc Ital Biol Sper; 1981 Jul; 57(14):1517-23. PubMed ID: 6794581
[TBL] [Abstract][Full Text] [Related]
58. Carrier-induced tolerance to nucleic acid antigens.
Stollar BD; Borel Y
J Immunol; 1975 Oct; 115(4):1095-110. PubMed ID: 51874
[TBL] [Abstract][Full Text] [Related]
59. Keyhole limpet hemocyanin: molecular structure of a potent marine immunoactivator. A review.
Harris JR; Markl J
Eur Urol; 2000; 37 Suppl 3():24-33. PubMed ID: 10828684
[TBL] [Abstract][Full Text] [Related]
60. Preclinical Efficacy and Characterization of Candidate Vaccines for Treatment of Opioid Use Disorders Using Clinically Viable Carrier Proteins.
Baruffaldi F; Kelcher AH; Laudenbach M; Gradinati V; Limkar A; Roslawski M; Birnbaum A; Lees A; Hassler C; Runyon S; Pravetoni M
Mol Pharm; 2018 Nov; 15(11):4947-4962. PubMed ID: 30240216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
